newsfilter
← Latest News
GlobeNewswire·

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced that G1's Chief Executive Officer Jack Bailey will provide a